ArticleFrontiers in pharmacology2024

Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.

Junting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.